In vitro and in vivo evidence for anti-inflammatory properties of 2-methoxyestradiol

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 3, 2011, Pages 962-972

  Shand, F H W ^a   Langenbach, S Y ^a   Keenan, C R ^a   Ma, S P ^a   Wheaton, B J ^a   Schuliga, M J ^a   Ziogas, J ^a   Stewart, Alastair ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; COLCHICINE; DEXAMETHASONE; ESTRADIOL; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MIFEPRISTONE; PACLITAXEL; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; LUNG LAVAGE; MACROPHAGE ACTIVATION; MICROTUBULE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; RNA EXTRACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELLS, CULTURED; ESTRADIOL; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MICE, INBRED BALB C; PNEUMONIA;

EID: 79951981414     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.174854     Document Type: Article

References (40)

1. Axelrod L (1976) Glucocorticoid therapy. Medicine 55:39-65.
2. Ballard PL and Ballard RA (1972) Glucocorticoid receptors and the role of glucocorticoids in fetal lung development. Proc Natl Acad Sci USA 69:2668-2672.
3. 125I-labelled ligand. Acta Endocrinol 103:282-288.
4. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, and Anderson GP (2004) Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am J Physiol Lung Cell Mol Physiol 286:L877-L885. (Pubitemid 38365075)
5. D'Amato RJ, Lin CM, Flynn E, Folkman J, and Hamel E (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968. (Pubitemid 24139553)
6. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, and Balaguer P (2006) Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor α or β. Biochem Pharmacol 71:1459-1469.
7. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, and Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237-239. (Pubitemid 24108838)
8. Fu P, Birukova AA, Xing J, Sammani S, Murley JS, Garcia JG, Grdina DJ, and Birukov KG (2009) Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J 33:612-624.
9. Hayashi T, Yamada K, Esaki T, Muto E, Chaudhuri G, and Iguchi A (1998) Physiological concentrations of 17β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J Cardiovasc Pharmacol 31:292-298. (Pubitemid 28099171)
10. Ho A, Kim YE, Lee H, Cyrus K, Baek SH, and Kim KB (2006) SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms. Bioorg Med Chem Lett 16:3383-3387. (Pubitemid 43777095)
11. Huerta-Yepez S, Baay-Guzman GJ, Garcia-Zepeda R, Hernandez-Pando R, Vega MI, Gonzalez-Bonilla C, and Bonavida B (2008) 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model. Clin Immunol 129:313-324.
12. Hughes RA, Harris T, Altmann E, McAllister D, Vlahos R, Robertson A, Cushman M, Wang Z, and Stewart AG (2002) 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding. Mol Pharmacol 61:1053-1069. (Pubitemid 34441770)
13. Issekutz AC and Sapru K (2008) Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action. Int Immunopharmacol 8:708-716.
14. Jordan A, Hadfield JA, Lawrence NJ, and McGown AT (1998) Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 18:259-296. (Pubitemid 28346389)
15. Josefsson E and Tarkowski A (1997) Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum 40:154-163. (Pubitemid 27044047)
16. Koay MA, Gao X, Washington MK, Parman KS, Sadikot RT, Blackwell TS, and Christman JW (2002) Macrophages are necessary for maximal nuclear factor-κB activation in response to endotoxin. Am J Respir Cell Mol Biol 26:572-578. (Pubitemid 34315865)
17. Koehler KF, Helguero LA, Haldosén LA, Warner M, and Gustafsson JA (2005) Reflections on the discovery and significance of estrogen receptor β. Endocr Rev 26:465-478. (Pubitemid 40691301)
18. Langenbach SY, Wheaton BJ, Fernandes DJ, Jones C, Sutherland TE, Wraith BC, Harris T, Schuliga MJ, McLean C, and Stewart AG (2007) Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice. Can J Physiol Pharmacol 85:727-738. (Pubitemid 350033270)
19. LaVallee TM, Burke PA, Swartz GM, Hamel E, Agoston GE, Shah J, Suwandi L, Hanson AD, Fogler WE, Sidor CF, et al. (2008) Significant antitumor activity in vivo following treatment with the microtubule agent ENMD-1198. Mol Cancer Ther 7:1472-1482.
20. Linden M and Brattsand R (1994) Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1β, and IL-6. Pulm Pharmacol 7:43-47. (Pubitemid 24101686)
21. 2 production in human U937-derived macrophages. Mol Cell Biochem 262:101-110.
22. Manthey CL, Perera PY, Salkowski CA, and Vogel SN (1994) Taxol provides a second signal for murine macrophage tumoricidal activity. J Immunol 152:825-831. (Pubitemid 24072987)
23. Mantovani A (1982) The interaction of cancer chemotherapy agents with mononuclear phagocytes. Adv Pharmacol Chemother 19:35-66.
24. Maran A, Gorny G, Oursler MJ, Zhang M, Shogren KL, Yaszemski MJ, and Turner RT (2006) 2-Methoxyestradiol inhibits differentiation and is cytotoxic to osteoclasts. J Cell Biochem 99:425-434. (Pubitemid 44435560)
25. Maus UA, Koay MA, Delbeck T, Mack M, Ermert M, Ermert L, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, et al. (2002) Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am J Physiol Lung Cell Mol Physiol 282:L1245-L1252.
26. Mestas J and Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172:2731-2738. (Pubitemid 38263654)
27. Mollinedo F and Gajate C (2003) Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8:413-450. (Pubitemid 37247987)
28. Mooberry SL (2003) Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 6:355-361.
29. Nathan C (2002) Points of control in inflammation. Nature 420:846-852.
30. Plum SM, Park EJ, Strawn SJ, Moore EG, Sidor CF, and Fogler WE (2009) Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis. BMC Musculoskelet Disord 10:46-58.
31. Rao P, Falk LA, Dougherty SF, Sawada T, and Pluznik DH (1997) Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages. J Immunol 159:3531-3539. (Pubitemid 127482112)
32. Sakazaki H, Ido R, Ueno H, and Nakamuro K (2005) 17β-estradiol primes elicitation of inducible nitric oxide synthase expression by lipopolysaccharide and interferon-γ in mouse macrophage cell line J774.1. J Health Sci 51:62-69. (Pubitemid 40626944)
33. Stewart AG (1999) inventor; Amrad Operations Pty Ltd, assignee. Treatment of asthma and airway diseases. U.S. patent 5,962,445. 1999 Oct 5.
34. Sutherland TE, Anderson RL, Hughes RA, Altmann E, Schuliga M, Ziogas J, and Stewart AG (2007) 2-Methoxyestradiol-a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discov Today 12:577-584. (Pubitemid 47031662)
35. Sutherland TE, Schuliga M, Harris T, Eckhardt BL, Anderson RL, Quan L, and Stewart AG (2005) 2-Methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer. Clin Cancer Res 11:1722-1732. (Pubitemid 40471833)
36. Szarka RJ, Wang N, Gordon L, Nation PN, and Smith RH (1997) A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods 202:49-57. (Pubitemid 27104267)
37. Tofovic SP, Zhang X, Jackson EK, Zhu H, and Petrusevska G (2009) 2-Methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats. Vascul Pharmacol 51:190-197.
38. Vegeto E, Ghisletti S, Meda C, Etteri S, Belcredito S, and Maggi A (2004) Regulation of the lipopolysaccharide signal transduction pathway by 17β-estradiol in macrophage cells. J Steroid Biochem Mol Biol 91:59-66. (Pubitemid 38903184)
39. Yan J, Chen C, Lei J, Yang L, Wang K, Liu J, and Zhou C (2006) 2-Methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats. Exp Neurol 202:348-356. (Pubitemid 44692678)
40. Yang YY, Olofsson M, Köpf I, and Hultborn R (1998) Growth and clonogenic assays compared for irradiated MCF-7 and Colo-205 cell lines. Anticancer Res 18:53-59. (Pubitemid 28174684)